Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Estradiol in Pessary Management
NCT05458375Phase 1Terminated
- Sponsor
- University of South Florida
- Start
- Dec 2022
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of estradiol topical in vaginal atrophy (2 arms), sponsored by University of South Florida. Primary endpoint: Pessary Discontinuation Rates at 6 months. Started Dec 2022; status: terminated.
02
Drugs
estradiol topical
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT05458375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05458375.